Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Risk analysis of antimicrobial resistance in outpatient urinary tract infections of young healthy adults.

Brosh-Nissimov T, Navon-Venezia S, Keller N, Amit S.

J Antimicrob Chemother. 2019 Feb 1;74(2):499-502. doi: 10.1093/jac/dky424.

PMID:
30357329
2.

Plasma Activation of a Breast Implant Shell in Conjunction With Antibacterial Irrigants Enhances Antibacterial Activity.

Barnea Y, Hammond DC, Geffen Y, Navon-Venezia S, Goldberg K.

Aesthet Surg J. 2018 Oct 15;38(11):1188-1196. doi: 10.1093/asj/sjy020.

PMID:
29378017
3.

Adhesion and invasion to epithelial cells and motility of extended-spectrum β-lactamase-producing Escherichia coli reveal ST131 superiority: a comparative in vitro study of extraintestinal pathogenic E. coli lineages.

Kondratyeva K, Wollman A, Gerlitz G, Navon-Venezia S.

J Med Microbiol. 2017 Sep;66(9):1350-1357. doi: 10.1099/jmm.0.000549. Epub 2017 Aug 22.

PMID:
28825894
4.

Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance.

Navon-Venezia S, Kondratyeva K, Carattoli A.

FEMS Microbiol Rev. 2017 May 1;41(3):252-275. doi: 10.1093/femsre/fux013. Review.

PMID:
28521338
5.

Draft Genome Sequences of Two Multidrug-Resistant Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae Strains Causing Bloodstream Infections.

Carasso E, Salmon-Divon M, Carmeli Y, Banin E, Navon-Venezia S.

Genome Announc. 2016 Jan 21;4(1). pii: e01533-15. doi: 10.1128/genomeA.01533-15.

6.

Genomic and Functional Characterization of qnr-Encoding Plasmids from Municipal Wastewater Biosolid Klebsiella pneumoniae Isolates.

Kaplan E, Sela N, Doron-Faigenboim A, Navon-Venezia S, Jurkevitch E, Cytryn E.

Front Microbiol. 2015 Dec 8;6:1354. doi: 10.3389/fmicb.2015.01354. eCollection 2015.

7.

Efficacy of dalbavancin in the treatment of MRSA rat sternal osteomyelitis with mediastinitis.

Barnea Y, Lerner A, Aizic A, Navon-Venezia S, Rachi E, Dunne MW, Puttagunta S, Carmeli Y.

J Antimicrob Chemother. 2016 Feb;71(2):460-3. doi: 10.1093/jac/dkv357. Epub 2015 Oct 30.

PMID:
26518048
8.

Prevalence and risk factors for colonization with methicillin resistant Staphylococcus aureus and other Staphylococci species in hospitalized and farm horses in Israel.

Tirosh-Levy S, Steinman A, Carmeli Y, Klement E, Navon-Venezia S.

Prev Vet Med. 2015 Nov 1;122(1-2):135-44. doi: 10.1016/j.prevetmed.2015.09.007. Epub 2015 Sep 16.

PMID:
26417658
9.

Persistence of Klebsiella pneumoniae ST258 as the predominant clone of carbapenemase-producing Enterobacteriaceae in post-acute-care hospitals in Israel, 2008-13.

Adler A, Hussein O, Ben-David D, Masarwa S, Navon-Venezia S, Schwaber MJ, Carmeli Y; Post-Acute-Care Hospital Carbapenem-Resistant Enterobacteriaceae Working Group.

J Antimicrob Chemother. 2015 Jan;70(1):89-92. doi: 10.1093/jac/dku333. Epub 2014 Sep 8.

PMID:
25204343
10.

Laboratory evaluation of different agar media for isolation of carbapenem-resistant Acinetobacter spp.

Moran-Gilad J, Adler A, Schwartz D, Navon-Venezia S, Carmeli Y.

Eur J Clin Microbiol Infect Dis. 2014 Nov;33(11):1909-13. doi: 10.1007/s10096-014-2159-y. Epub 2014 May 28.

PMID:
24865248
11.

Persistence and complex evolution of fluoroquinolone-resistant Streptococcus pneumoniae clone.

Ben-David D, Schwaber MJ, Adler A, Masarwa S, Edgar R, Navon-Venezia S, Schwartz D, Porat N, Kotlovsky T, Polivkin N, Weinberg I, Lazary A, Ohana N, Dagan R.

Emerg Infect Dis. 2014 May;20(5):799-805. doi: 10.3201/eid2005.130142.

12.

Mix and match of KPC-2 encoding plasmids in Enterobacteriaceae-comparative genomics.

Chmelnitsky I, Shklyar M, Leavitt A, Sadovsky E, Navon-Venezia S, Ben Dalak M, Edgar R, Carmeli Y.

Diagn Microbiol Infect Dis. 2014 Jun;79(2):255-60. doi: 10.1016/j.diagmicrobio.2014.03.008. Epub 2014 Mar 17.

PMID:
24743043
13.

Biofilm formation and susceptibility to gentamicin and colistin of extremely drug-resistant KPC-producing Klebsiella pneumoniae.

Naparstek L, Carmeli Y, Navon-Venezia S, Banin E.

J Antimicrob Chemother. 2014 Apr;69(4):1027-34. doi: 10.1093/jac/dkt487. Epub 2014 Jan 9.

PMID:
24408988
14.

Ceftobiprole medocaril is an effective treatment against methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis in a rat model.

Barnea Y, Navon-Venezia S, Kuzmenko B, Artzi N, Carmeli Y.

Eur J Clin Microbiol Infect Dis. 2014 Mar;33(3):325-9. doi: 10.1007/s10096-013-1959-9. Epub 2013 Sep 14.

PMID:
24030718
15.

Outbreak of multidrug-resistant Pseudomonas aeruginosa infection following urodynamic studies traced to contaminated transducer.

Bilavsky E, Pfeffer I, Tarabeia J, Schechner V, Abu-Hanna J, Grisaru-Soen G, Schwartz D, Navon-Venezia S, Carmeli Y.

J Hosp Infect. 2013 Apr;83(4):344-6. doi: 10.1016/j.jhin.2013.01.003. Epub 2013 Feb 16.

PMID:
23419597
16.

Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage.

Feldman N, Adler A, Molshatzki N, Navon-Venezia S, Khabra E, Cohen D, Carmeli Y.

Clin Microbiol Infect. 2013 Apr;19(4):E190-6. doi: 10.1111/1469-0691.12099. Epub 2013 Jan 17.

17.

Rectal swabs are suitable for quantifying the carriage load of KPC-producing carbapenem-resistant Enterobacteriaceae.

Lerner A, Romano J, Chmelnitsky I, Navon-Venezia S, Edgar R, Carmeli Y.

Antimicrob Agents Chemother. 2013 Mar;57(3):1474-9. doi: 10.1128/AAC.01275-12. Epub 2013 Jan 7.

18.

Clonal transmission of a rare methicillin-resistant Staphylococcus aureus genotype between horses and staff at a veterinary teaching hospital.

Schwaber MJ, Navon-Venezia S, Masarwa S, Tirosh-Levy S, Adler A, Chmelnitsky I, Carmeli Y, Klement E, Steinman A.

Vet Microbiol. 2013 Mar 23;162(2-4):907-11. doi: 10.1016/j.vetmic.2012.11.020. Epub 2012 Nov 26.

PMID:
23265243
19.

The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel.

Karfunkel D, Carmeli Y, Chmelnitsky I, Kotlovsky T, Navon-Venezia S.

Eur J Clin Microbiol Infect Dis. 2013 Apr;32(4):513-21. doi: 10.1007/s10096-012-1765-9. Epub 2012 Nov 2.

PMID:
23117265
20.

Environmental contamination by carbapenem-resistant Enterobacteriaceae.

Lerner A, Adler A, Abu-Hanna J, Meitus I, Navon-Venezia S, Carmeli Y.

J Clin Microbiol. 2013 Jan;51(1):177-81. doi: 10.1128/JCM.01992-12. Epub 2012 Oct 31.

21.

Novel rat model of methicillin-resistant Staphylococcus aureus-infected silicone breast implants: a study of biofilm pathogenesis.

Arad E, Navon-Venezia S, Gur E, Kuzmenko B, Glick R, Frenkiel-Krispin D, Kramer E, Carmeli Y, Barnea Y.

Plast Reconstr Surg. 2013 Feb;131(2):205-14. doi: 10.1097/PRS.0b013e3182778590.

PMID:
23076419
22.

Unique genes identified in the epidemic extremely drug-resistant KPC-producing Klebsiella pneumoniae sequence type 258.

Chmelnitsky I, Shklyar M, Hermesh O, Navon-Venezia S, Edgar R, Carmeli Y.

J Antimicrob Chemother. 2013 Jan;68(1):74-83. doi: 10.1093/jac/dks370. Epub 2012 Oct 4. Erratum in: J Antimicrob Chemother. 2013 Sep;68(9):2178.

PMID:
23042812
23.

Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected?

Schechner V, Kotlovsky T, Kazma M, Mishali H, Schwartz D, Navon-Venezia S, Schwaber MJ, Carmeli Y.

Clin Microbiol Infect. 2013 May;19(5):451-6. doi: 10.1111/j.1469-0691.2012.03888.x. Epub 2012 May 7.

24.

Reduced susceptibility to chlorhexidine among extremely-drug-resistant strains of Klebsiella pneumoniae.

Naparstek L, Carmeli Y, Chmelnitsky I, Banin E, Navon-Venezia S.

J Hosp Infect. 2012 May;81(1):15-9. doi: 10.1016/j.jhin.2012.02.007. Epub 2012 Mar 30.

PMID:
22463977
25.

Introduction of OXA-48-producing Enterobacteriaceae to Israeli hospitals by medical tourism.

Adler A, Shklyar M, Schwaber MJ, Navon-Venezia S, Dhaher Y, Edgar R, Solter E, Benenson S, Masarwa S, Carmeli Y.

J Antimicrob Chemother. 2011 Dec;66(12):2763-6.

PMID:
22191089
26.

Laboratory evaluation of the ESwab transport system for the recovery of carbapenem-resistant Acinetobacter baumannii.

Moran-Gilad J, Schwartz D, Navon-Venezia S, Carmeli Y.

Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1429-33. doi: 10.1007/s10096-011-1460-2. Epub 2011 Nov 9.

PMID:
22068274
27.

Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Israel: dissemination of global clones and unique features.

Adler A, Chmelnitsky I, Shitrit P, Sprecher H, Navon-Venezia S, Embon A, Khabra E, Paitan Y, Keren L, Halperin E, Carmeli Y, Schwaber MJ.

J Clin Microbiol. 2012 Jan;50(1):134-7. doi: 10.1128/JCM.05446-11. Epub 2011 Oct 26.

28.

High prevalence of methicillin-resistant Staphylococcus aureus among residents and staff of long-term care facilities, involving joint and parallel evolution.

Schwaber MJ, Masarwa S, Navon-Venezia S, Kandlik Y, Chmelnitsky I, Smollan G, Glick R, Neria G, Carmeli Y.

Clin Infect Dis. 2011 Nov;53(9):910-3. doi: 10.1093/cid/cir607. Erratum in: Clin Infect Dis. 2012 Oct;55(8):1170.

PMID:
21984272
29.

Carbapenem-resistant Klebsiella pneumoniae in post-acute-care facilities in Israel.

Ben-David D, Masarwa S, Navon-Venezia S, Mishali H, Fridental I, Rubinovitch B, Smollan G, Carmeli Y, Schwaber MJ; Israel PACF CRKP (Post-Acute-Care Facility Carbapenem-Resistant Klebsiella pneumoniae) Working Group.

Infect Control Hosp Epidemiol. 2011 Sep;32(9):845-53. doi: 10.1086/661279. Erratum in: Infect Control Hosp Epidemiol. 2014 Sep;35(9):1208.

PMID:
21828964
30.

Laboratory evaluation of the CHROMagar KPC medium for identification of carbapenem-nonsusceptible Enterobacteriaceae.

Moran Gilad J, Carmeli Y, Schwartz D, Navon-Venezia S.

Diagn Microbiol Infect Dis. 2011 Aug;70(4):565-7. doi: 10.1016/j.diagmicrobio.2010.03.005.

PMID:
21767716
31.

The effects of group 1 versus group 2 carbapenems on imipenem-resistant Pseudomonas aeruginosa: an ecological study.

Carmeli Y, Lidji SK, Shabtai E, Navon-Venezia S, Schwaber MJ.

Diagn Microbiol Infect Dis. 2011 Jul;70(3):367-72. doi: 10.1016/j.diagmicrobio.2011.03.009.

PMID:
21683268
32.

Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter.

Schechner V, Kotlovsky T, Tarabeia J, Kazma M, Schwartz D, Navon-Venezia S, Carmeli Y.

Infect Control Hosp Epidemiol. 2011 May;32(5):497-503. doi: 10.1086/659762.

PMID:
21515981
33.

Laboratory and clinical evaluation of screening agar plates for detection of carbapenem-resistant Enterobacteriaceae from surveillance rectal swabs.

Adler A, Navon-Venezia S, Moran-Gilad J, Marcos E, Schwartz D, Carmeli Y.

J Clin Microbiol. 2011 Jun;49(6):2239-42. doi: 10.1128/JCM.02566-10. Epub 2011 Apr 6.

34.

Plasmid-encoded OXA-48 carbapenemase in Escherichia coli from Israel.

Goren MG, Chmelnitsky I, Carmeli Y, Navon-Venezia S.

J Antimicrob Chemother. 2011 Mar;66(3):672-3. doi: 10.1093/jac/dkq467. Epub 2010 Dec 21. No abstract available.

PMID:
21177669
35.

Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan.

Marchaim D, Chopra T, Pogue JM, Perez F, Hujer AM, Rudin S, Endimiani A, Navon-Venezia S, Hothi J, Slim J, Blunden C, Shango M, Lephart PR, Salimnia H, Reid D, Moshos J, Hafeez W, Bheemreddy S, Chen TY, Dhar S, Bonomo RA, Kaye KS.

Antimicrob Agents Chemother. 2011 Feb;55(2):593-9. doi: 10.1128/AAC.01020-10. Epub 2010 Nov 29.

36.

Complete nucleotide sequence of KPC-3-encoding plasmid pKpQIL in the epidemic Klebsiella pneumoniae sequence type 258.

Leavitt A, Chmelnitsky I, Carmeli Y, Navon-Venezia S.

Antimicrob Agents Chemother. 2010 Oct;54(10):4493-6. doi: 10.1128/AAC.00175-10. Epub 2010 Aug 9.

37.

Transfer of carbapenem-resistant plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in patient.

Goren MG, Carmeli Y, Schwaber MJ, Chmelnitsky I, Schechner V, Navon-Venezia S.

Emerg Infect Dis. 2010 Jun;16(6):1014-7. doi: 10.3201/eid1606.091671.

38.

Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.

Leavitt A, Carmeli Y, Chmelnitsky I, Goren MG, Ofek I, Navon-Venezia S.

Antimicrob Agents Chemother. 2010 Jul;54(7):3002-6. doi: 10.1128/AAC.01818-09. Epub 2010 Mar 29.

39.

Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.

Goren MG, Navon-Venezia S, Chmelnitsky I, Carmeli Y.

Antimicrob Agents Chemother. 2010 Jun;54(6):2687-91. doi: 10.1128/AAC.01359-09. Epub 2010 Mar 15.

40.

Intercontinental spread from Israel to Colombia of a KPC-3-producing Klebsiella pneumoniae strain.

Lopez JA, Correa A, Navon-Venezia S, Correa AL, Torres JA, Briceño DF, Montealegre MC, Quinn JP, Carmeli Y, Villegas MV.

Clin Microbiol Infect. 2011 Jan;17(1):52-6. doi: 10.1111/j.1469-0691.2010.03209.x.

41.

Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system.

Reddy T, Chopra T, Marchaim D, Pogue JM, Alangaden G, Salimnia H, Boikov D, Navon-Venezia S, Akins R, Selman P, Dhar S, Kaye KS.

Antimicrob Agents Chemother. 2010 May;54(5):2235-8. doi: 10.1128/AAC.01665-09. Epub 2010 Mar 8.

42.

Plasmid pKpQIL encoding KPC-3 and TEM-1 confers carbapenem resistance in an extremely drug-resistant epidemic Klebsiella pneumoniae strain.

Leavitt A, Chmelnitsky I, Ofek I, Carmeli Y, Navon-Venezia S.

J Antimicrob Chemother. 2010 Feb;65(2):243-8. doi: 10.1093/jac/dkp417. Epub 2009 Nov 24.

PMID:
19939824
43.

Parental Staphylococcus aureus carriage is associated with staphylococcal carriage in young children.

Regev-Yochay G, Raz M, Carmeli Y, Shainberg B, Navon-Venezia S, Pinco E, Leavitt A, Keller N, Rahav G, Malley R, Rubinstein E; Maccabi Implementing Judicious Antibiotic Prescription Study Group.

Pediatr Infect Dis J. 2009 Nov;28(11):960-5. doi: 10.1097/INF.0b013e3181a90883.

PMID:
19738508
44.

Evaluation of PCR-based testing for surveillance of KPC-producing carbapenem-resistant members of the Enterobacteriaceae family.

Schechner V, Straus-Robinson K, Schwartz D, Pfeffer I, Tarabeia J, Moskovich R, Chmelnitsky I, Schwaber MJ, Carmeli Y, Navon-Venezia S.

J Clin Microbiol. 2009 Oct;47(10):3261-5. doi: 10.1128/JCM.02368-08. Epub 2009 Aug 12.

45.

Detection of aac(6')-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from Tel Aviv, Israel.

Chmelnitsky I, Hermesh O, Navon-Venezia S, Strahilevitz J, Carmeli Y.

J Antimicrob Chemother. 2009 Oct;64(4):718-22. doi: 10.1093/jac/dkp272. Epub 2009 Aug 4.

PMID:
19656782
46.

Biennial hyperepidemic shigellosis in an observant Jewish community.

Calderon-Margalit R, Navon-Venezia S, Gefen D, Amitai Z, Barda R, Vulikh I, Sompolinsky D.

Epidemiol Infect. 2010 Feb;138(2):244-52. doi: 10.1017/S0950268809990379. Epub 2009 Jul 14.

PMID:
19602299
47.

Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258.

Kitchel B, Rasheed JK, Patel JB, Srinivasan A, Navon-Venezia S, Carmeli Y, Brolund A, Giske CG.

Antimicrob Agents Chemother. 2009 Aug;53(8):3365-70. doi: 10.1128/AAC.00126-09. Epub 2009 Jun 8.

48.

Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult. Successful treatment with gentamicin and colistin.

Benenson S, Navon-Venezia S, Carmeli Y, Adler A, Strahilevitz J, Moses AE, Block C.

Int J Infect Dis. 2009 Sep;13(5):e295-8. doi: 10.1016/j.ijid.2009.01.006. Epub 2009 Mar 28.

49.

Ertapenem resistance among extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae isolates.

Leavitt A, Chmelnitsky I, Colodner R, Ofek I, Carmeli Y, Navon-Venezia S.

J Clin Microbiol. 2009 Apr;47(4):969-74. doi: 10.1128/JCM.00651-08. Epub 2009 Feb 11.

50.

First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States.

Navon-Venezia S, Leavitt A, Schwaber MJ, Rasheed JK, Srinivasan A, Patel JB, Carmeli Y; Israeli KPC Kpn Study Group.

Antimicrob Agents Chemother. 2009 Feb;53(2):818-20. doi: 10.1128/AAC.00987-08. Epub 2008 Nov 24.

Supplemental Content

Loading ...
Support Center